Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedA banner announces an NIH website terminology transition, stating that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) under Executive Order 14434.SummaryDifference0.4%

- Check12 days agoChange DetectedThe website footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry, v3.7.0, was added to the study history. The previous revision v3.6.6 was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedAn updated revision label (v3.6.6) was added to the history page, replacing the previous v3.6.5. This reflects a new build of the page for record-keeping.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry v3.6.5 appears in the page history, replacing the previous v3.6.4, indicating an update to the record history metadata.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.